Distributed worldwide by Onco Solution, this innovative medication leverages the glucagon-like peptide-1 receptor agonist (GLP-1 RA) mechanism to substantially enhance blood sugar regulation and facilitate weight loss, heralding a new era in diabetes care
Your Medical History: Do you have type 2 diabetes, established cardiovascular disease, thyroid issues, or a history of pancreatitis
The goal is finding the minimum effective dose that provides appetite support and energy enhancement without unwanted effects
We found no interactions, except between prior suicide attempts and sex in the comparison of GLP-1 RAs and SGLT-2 inhibitors, indicating that the effect of prior suicide attempts on the risk of a subsequent suicide attempt is greater among men
This is important because GLP-1 drugs were originally designed to have a long half-life in blood to maximise their efficacy in the treatment of diabetes which prevents them from entering the brain (Hlscher)